CERo Therapeutics Correlations

CEROW Stock

0.01 0 66.67%

The current 90-days correlation between CERo Therapeutics and NetSol Technologies is 0.31 (i.e., Weak diversification). The correlation of CERo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

CERo Therapeutics Correlation With Market

Average diversification

The correlation between CERo Therapeutics Holdings and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Moving together with CERo Stock

0.7	CDIOW	Cardio Diagnostics	Pair Corr
0.68	VIRX	Viracta Therapeutics	Pair Corr
0.67	VNDA	Vanda Pharmaceuticals	Pair Corr
0.71	CDTTW	Conduit Pharmaceuticals Symbol Change	Pair Corr
0.64	VSTM	Verastem	Pair Corr
0.65	EFTR	Effector Therapeutics	Pair Corr

Moving against CERo Stock

0.83	DMAC	DiaMedica Therapeutics Downward Rally	Pair Corr
0.53	DNLI	Denali Therapeutics	Pair Corr
0.52	DNTH	Dianthus Therapeutics	Pair Corr
0.52	VCYT	Veracyte	Pair Corr
0.41	DRUG	Bright Minds Biosciences	Pair Corr
0.4	KA	Kineta Inc	Pair Corr
0.37	EQ	Equillium	Pair Corr
0.36	VERA	Vera Therapeutics	Pair Corr
0.33	VAXX	Vaxxinity	Pair Corr
0.73	VRNA	Verona Pharma PLC	Pair Corr
0.47	VKTX	Viking Therapeutics	Pair Corr
0.35	VRPX	Virpax Pharmaceuticals	Pair Corr
0.35	EDSA	Edesa Biotech Fiscal Year End 20th of December 2024	Pair Corr
0.31	VXRT	Vaxart Inc	Pair Corr

Related Correlations Analysis

	NTWK	QLYS	JYNT	TFX	MMSI	CTKB	DDOG	BILL
NTWK		0.36	0.31	0.23	0.0	0.65	-0.08	0.34	NTWK
QLYS	0.36		0.93	-0.69	-0.78	0.75	0.66	0.16	QLYS
JYNT	0.31	0.93		-0.77	-0.84	0.72	0.59	0.08	JYNT
TFX	0.23	-0.69	-0.77		0.91	-0.24	-0.6	0.23	TFX
MMSI	0.0	-0.78	-0.84	0.91		-0.48	-0.56	0.28	MMSI
CTKB	0.65	0.75	0.72	-0.24	-0.48		0.34	0.28	CTKB
DDOG	-0.08	0.66	0.59	-0.6	-0.56	0.34		0.31	DDOG
BILL	0.34	0.16	0.08	0.23	0.28	0.28	0.31		BILL
	NTWK	QLYS	JYNT	TFX	MMSI	CTKB	DDOG	BILL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

JYNT	+ 0.93	QLYS
MMSI	+ 0.91	TFX
CTKB	+ 0.75	QLYS
CTKB	+ 0.72	JYNT
DDOG	+ 0.66	QLYS
CTKB	+ 0.65	NTWK

High negative correlations

MMSI	- 0.84	JYNT
MMSI	- 0.78	QLYS
TFX	- 0.77	JYNT
TFX	- 0.69	QLYS
DDOG	- 0.6	TFX
DDOG	- 0.56	MMSI

Risk-Adjusted Indicators

There is a big difference between CERo Stock performing well and CERo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CERo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NTWK	1.80	(0.09)	(0.05)	0.01	1.93	(2.14)	4.67	(3.25)	13.17
QLYS	1.52	(0.31)	0.00	(0.09)	0.00	0.00	2.61	(2.99)	12.63
JYNT	2.23	(0.51)	0.00	(0.14)	0.00	0.00	4.92	(6.12)	16.09
TFX	1.07	0.18	0.08	0.59	1.10	(1.16)	2.99	(1.79)	9.19
MMSI	0.97	0.23	0.15	0.74	0.70	(1.07)	2.45	(1.37)	6.96
CTKB	3.12	(0.35)	0.00	(0.05)	0.00	0.00	5.21	(6.10)	24.39
DDOG	1.66	(0.22)	0.00	(0.07)	0.00	0.00	2.55	(4.36)	11.62
BILL	2.15	(0.04)	0.00	0.07	2.61	(2.25)	5.10	(5.07)	12.57

CERo Therapeutics Corporate Executives

Elected by the shareholders, the CERo Therapeutics' board of directors comprises two types of representatives: CERo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CERo. The board's role is to monitor CERo Therapeutics' management team and ensure that shareholders' interests are well served. CERo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CERo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

	Lawrence MD	Cofounder Board	Profile
	Charles Carter	Treasurer, CFO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC